Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 1, Open-Label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors
This study is currently recruiting participants.
Study NCT00492830.   Last updated on September 30, 2008.
Information provided by Tracon Pharmaceuticals Inc.
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Neoplasm Metastasis
More general conditions related to this trial
Neoplasms
Neoplastic Processes
Pathologic Processes
Additional drug interventions recognized in this trial
Antibodies
Antibodies, Monoclonal
Immunoglobulins
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Tracon Pharmaceuticals Inc.


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services